RECRUITINGINTERVENTIONAL
Reliability of IUS in Crohn's Disease
About This Trial
Transabdominal intestinal ultrasound (IUS) is gaining acceptance as a point-of-care test to objectively assess disease activity in Crohn's disease (CD). In order to incorporate individual parameters in a future definition of transmural healing, and for the consistent application of IUS as a modality to assess treatment outcomes and establish therapeutic targets to ensure comparability between future studies, the inter-observer agreement should be determined for all relevant parameters.
Who May Be Eligible (Plain English)
Who May Qualify:
- Crohn's disease evolving for at least 1 months
- Patient older than 18 years
- Patient covered by French national health insurance
- Written willing to sign a consent form
Who Should NOT Join This Trial:
- Pregnant women or breastfeeding
- Minor
- Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision)
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Crohn's disease evolving for at least 1 months
* Patient older than 18 years
* Patient covered by French national health insurance
* Written informed consent
Exclusion Criteria:
* Pregnant women or breastfeeding
* Minor
* Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision)
Treatments Being Tested
OTHER
Transabdominal intestinal ultrasound
Transabdominal intestinal ultrasound
Locations (1)
CHU d'Amiens
Amiens, France